Brief: Cipla Says USFDA Inspection At Invagen Manufacturing Facility In Hauppauge, Long Island, New York, USA
10/02/2026 05:43
Feb 10 (Reuters) - Cipla Ltd CIPL.NS: CIPLA - USFDA INSPECTION AT INVAGEN MANUFACTURING FACILITY IN HAUPPAUGE, LONG ISLAND, NEW YORK, USA CIPLA - ON CONCLUSION OF INSPECTION, INVAGEN HAS RECEIVED 2 INSPECTIONAL OBSERVATIONS Source text: ID:nNSEb8YkN0 Further company coverage: CIPL.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cipla
See all newsIndian pharma stocks up on report US taps drugmakers for critical cancer drug
India's Cipla jumps after Citi sees near-term positive triggers for earnings
Factbox: Global drugmakers invest billions to boost US presence
India raises price cap on cancer drugs to tackle shortage
Brief: Cipla Says USFDA Classified Verna Manufacturing Facility Inspection As Voluntary Action Indicated